Keros Therapeutics Reports Recent Business Highlights and Fi

LEXINGTON, Mass., May 04, 2023 -- Keros Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients... | May 4, 2023

Related Keywords

United States , American , Jasbirs Seehra , Justin Frantz , Alpna Seth , Company Annual Report On Form , International Conference , Cardiovascular Health , Globenewswire Inc , American Thoracic Society , Exchange Commission , Company Nasdaq , Keros Therapeutics Inc , Chief Executive , Thoracic Society , Modified Activin Receptor , Healthy Post Menopausal , Precision Based Approaches , Pulmonary Vascular , Presentation Time , Novel Modified , Attenuated Cardiac Remodeling , Transverse Aortic Constriction Model , Cardiopulmonary Vascular , Novel Activin Receptor Type , Ligand Trap , Inhibited Mediators , Dysregulated Vascular Remodeling , Pulmonary Endothelial , Smooth Muscle , Breaking Bad , New Drugs , Pulmonary Hypertension , Private Securities Litigation Reform Act , Annual Report , Consolidated Statements , Keros Therapeutics , Nc Stock Exchange , News , Information , Press Release , Bay , 023 , Heros , Iopharmaceutical , Company , Ocused , N , The , Development , End , Ommercialization , F , Novel , Treatments , Or Kros Us4923271013 ,